"10.1371_journal.pone.0132546","plos one","2015-07-13T00:00:00Z","Gorka Ruiz de Garibay; Carmen Herranz; Alicia Llorente; Jacopo Boni; Jordi Serra-Musach; Francesca Mateo; Helena Aguilar; Laia Gómez-Baldó; Anna Petit; August Vidal; Fina Climent; Javier Hernández-Losa; Álex Cordero; Eva González-Suárez; José Vicente Sánchez-Mut; Manel Esteller; Roger Llatjós; Mar Varela; José Ignacio López; Nadia García; Ana I Extremera; Anna Gumà; Raúl Ortega; María Jesús Plà; Adela Fernández; Sònia Pernas; Catalina Falo; Idoia Morilla; Miriam Campos; Miguel Gil; Antonio Román; María Molina-Molina; Piedad Ussetti; Rosalía Laporta; Claudia Valenzuela; Julio Ancochea; Antoni Xaubet; Álvaro Casanova; Miguel Angel Pujana","Program Against Cancer Therapeutic Resistance (ProCURE), Breast Cancer and Systems Biology, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain; Department of Pathology, University Hospital of Bellvitge, Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain; Department of Pathology, Vall d'Hebron Hospital, Barcelona, Catalonia, Spain; Cancer Epigenetics and Biology Program, Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain; Department of Physiological Sciences II, School of Medicine, University of Barcelona, Barcelona, Catalonia, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain; Cruces University Hospital, BioCruces Research Institute, University of the Basque Country, Barakaldo, Spain; Department of Radiology, University Hospital of Bellvitge, Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain; Department of Gynecology, University Hospital of Bellvitge, Breast Cancer Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain; Department of Medical Oncology, Breast Cancer Unit, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain; Department of Pulmonology, Lung Transplant Unit, Lymphangioleiomyomatosis (LAM) Clinic, Vall d'Hebron University Hospital, Barcelona, Catalonia, Spain; Department of Pneumology, University Hospital of Bellvitge, Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet del Llobregat, Catalonia, Spain; Biomedical Research Centre Network for Respiratory Diseases (CIBERES), Madrid, Spain; Department of Pneumology, University Hospital Clínica Puerta del Hierro, Madrid, Spain; Department of Pneumology, Instituto de Investigación Sanitaria La Princesa, Hospital La Princesa, Madrid, Spain; Department of Pneumology, Hospital Clinic of Barcelona, Agusti Pi Suñer Biomedical Research Institute (IDIBAPS), Barcelona, Catalonia, Spain; Department of Pneumology, Henares Hospital, Madrid, Spain","Conceived and designed the experiments: MAP. Performed the experiments: GRG CH AL JB JS-M FM HA LG-B JH-L JVS-M NG AIE MAP. Analyzed the data: GRG CH AL JS-M AP AV FC JVS-M R. Llatjós AR MM-M PU R. Laporta CV JA AX A. Casanova MAP. Contributed reagents/materials/analysis tools: A. Cordero EG-S ME MV JIL AG RO MJP AF SP CF IM MC MG AR MM-M PU R. Laporta CV JA AX A. Casanova. Wrote the paper: MAP.","The authors have declared that no competing interests exist.","2015","07","Gorka Ruiz de Garibay","GRDG",39,FALSE,1,13,9,1,TRUE,TRUE,TRUE,15,"13;14;16;18;19;24;26;27;28;29;30;32;33;35;38",TRUE
